Laura Godfrey

Functional noninvasive detection of glycolytic pancreatic ductal adenocarcinoma

R. Braren, W. Weichert, A. Tannapfel, 2022, Cancer & metabolism.

Epigenetic plasticity via adaptive DNA hypermethylation and clonal expansion underlie resistance to oncogenic pathway inhibition in pancreatic cancer

B. Sitek, A. Scarpa, R. Lawlor, 2022, bioRxiv.

MAPK-pathway inhibition mediates inflammatory reprogramming and sensitizes tumors to targeted activation of innate immunity sensor RIG-I

C. Schmitt, Roman K. Thomas, G. Hartmann, 2021, Nature Communications.

Molecular heterogeneity and commonalities in pancreatic cancer precursors with gastric and intestinal phenotype

A. Trumpp, W. Knoefel, W. Goering, 2022, Gut.

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models

S. Fröhling, B. Verdoodt, V. Heinemann, 2021, Genome Medicine.